A new study finds hope in sativa strains of cannabis.
The approval of injectable drug Vocabria sets up a treatment regimen that can be taken once a month or even every other month.
A federal study found Gilead's remdesivir cut recovery time in some COVID-19 patients.
Study finds increased weight gains with newer antiretroviral drugs.
The decision was announced just days before the Conference on Retroviruses and Opportunistic Infections was to take place.
A generic form of the HIV prevention drug from Teva Pharmaceuticals will come earlier than anticipated — but activists are calling for greater access.
An antibiotic commonly prescribed to treat an HIV-related illness might cause coronary problems years later.